The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1630
ISSUE1630
August 9, 2021
Ponesimod (Ponvory) for Multiple Sclerosis
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Ponesimod (Ponvory) for Multiple Sclerosis
August 9, 2021 (Issue: 1630)
The FDA has approved ponesimod (Ponvory –
Janssen), a sphingosine 1-phosphate (S1P) receptor
modulator, for treatment of adults with relapsing forms
of multiple sclerosis (MS), including clinically isolated
syndrome (initial neurological...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.